Profile
Michael A. Jacobsen formerly worked at ICOS Corp., as Senior Director-Finance & Corporate Controller, Sarepta Therapeutics, Inc., as Secretary, Chief Accounting Officer & VP-Finance from 2012 to 2013, ZymoGenetics, Inc., as Chief Accounting Officer & Vice President from 2007 to 2011, and Omeros Corp., as Chief Accounting Officer, Treasurer & VP from 2013 to 2024.
Mr. Jacobsen received his undergraduate degree in 1980 from Idaho State University.
Former positions of Michael Jacobsen
| Companies | Position | End |
|---|---|---|
| OMEROS CORPORATION | Director of Finance/CFO | 30/06/2024 |
| SAREPTA THERAPEUTICS, INC. | Director of Finance/CFO | 15/11/2011 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Chief Operating Officer | 01/08/2011 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Director of Finance/CFO | - |
Training of Michael Jacobsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Omeros Corp.
Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Idaho State University
Idaho State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Michael Jacobsen
















